Primaquine resistance in Plasmodium vivax

American Journal of Tropical Medicine and Hygiene

Volumn 55, Issue 3, 1996, Pages 243-249

  Collins, William E ^a   Jeffery, Geoffrey M ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOQUINOLINE DERIVATIVE; 8 AMINOQUINOLINE DERIVATIVE; CHLOROQUINE; DOXYCYCLINE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; MEFLOQUINE; PAMAQUINE; PENTAQUINE; PRIMAQUINE;

ABDOMINAL PAIN; ANOREXIA; ANTIMALARIAL ACTIVITY; BLOOD TOXICITY; HUMAN; LIFE CYCLE; MALARIA; MALARIA CONTROL; NAUSEA; PARASITE DEVELOPMENT; PLASMODIUM VIVAX; REVIEW; STRAIN DIFFERENCE; VOMITING;

PLASMODIUM VIVAX;

EID: 0029763407     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1996.55.243     Document Type: Review

References (65)

1. Krotoski WA, 1980. Frequency of relapse and primaquine resistance in Southeast Asian vivax malaria. N Engl J Med 303: 587.
2. Luzzi GA, Warrell DA, Barnes AJ, Dunbar EM, 1992. Treatment of primaquine-resistant Plasmodium vivax malaria. Lancet 340: 310.
3. Bunnag D, Karbwang J, Thanavibul A, Chittamas S, Ratanapongse Y, Chalermrut K, Bangshang KN, Harinasuta T, 1994. High dose of primaquine in primaquine resistant vivax malaria. Trans R Soc Trop Med Hyg 88: 218-219.
4. Charoenlarp P, Harinasuta T, 1973. Relapses of vivax malaria after a conventional course of primaquine and chloroquine. Report of two cases. Southeast Asian J Trop Med Public Health 3: 135-137.
5. Rombo L, Edwards G, Ward SA, Eriksson G, Lindquist L, Lindberg A, Runehagen A, Bjorkman A, Hylander NO, 1987. Seven patients with relapses of Plasmodium vivax or P. ovale despite primaquine treatment. Trop Med Parasitol 38: 49-50.
6. Cabezos J, Duran E, Tomas D, Bada JL, 1994. Resistencia de Plasmodium vivax a la primaquina. Med Clin (Barc) 103: 159.
7. Gascon J, Gomez Arce JE, Menendez C, Valls ME, Corachen M, 1994. Poor response to primaquine in two cases of Plasmodium vivax malaria from Guatemala. Trop Geogr Med 46: 32-33.
8. Ronn AM, Bygbjerg IC, 1993. Problemer med primakin-residiv-profylakse hos malariapatienter. Ugeskr Laeger 155: 3901-3904.
9. World Health Organization, 1963. Terminology of Malaria and of Malaria Eradication. Geneva: World Health Organization.
10. World Health Organization, 1965. Resistance of malaria parasites to drugs. World Health Organ Tech Rep Ser 296.
11. World Health Organization, 1973. Chemotherapy of malaria and resistance to antimalarials. World Health Organ Tech Rep Ser 529.
12. Rieckmann KH, Davis DR, Hutton DC, 1989. Plasmodium vivax resistance to chloroquine? Lancet 2: 1183-1184.
13. Whitby M, Wood G, Veenendaal JR, Rieckmann K, 1989. Chloroquine-resistant Plasmodium vivax. Lancet 2: 1389.
14. Baird JK, Basri H, Purnomo, Bangs MJ, Subianto B, Patchen LC, Hoffman SL, 1991. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am J Trop Med Hyg 44: 547-552.
15. Schwartz IK, Lackritz EM, Patchen LC, 1991. Chloroquineresistant Plasmodium vivax from Indonesia. N Engl J Med 324: 927.
16. Collins WE, Schwartz IK, Skinner JC, Morris C, Filipski VK, 1992. The susceptibility of the Indonesian I/CDC strain of Plasmodium vivax to chloroquine. J Parasitol 78: 344-349.
17. Schuurkamp GJ, Spicer PE, Kereu RK, Bulungol PK, Rieckmann KH, 1992. Chloroquine-resistant Plasmodium vivax in Papua New Guinea. Trans R Soc Trop Med Hyg 86: 121-122.
18. Murphy GS, Basri H, Puromo, Andersen EM, Wiady I, Bangs MJ, Mount DL, Gorden J, Lai AA, Purwokusumo AR, Harjosuwarno S, Sorensen K, Hoffman SL, 1993. Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet 341: 96-100.
19. Cooper RD, 1994. Studies of a chloroquine-resistant strain of Plasmodium vivax from Papua New Guinea in Aotus and Anopheles farauti s.l. J Parasitol 80: 789-795.
20. Cooper RD, 1995. Susceptibility of Guyanan Saimiri monkeys to a chloroquine-sensitive and a chloroquine-resistant strain of Plasmodium vivax from Papua New Guinea. J Parasitol 81: 640-641.
21. Baird JK, Basri H, Subianto B, Fryauff DJ, McElroy PD, Leksana B, Richie TL, Masbar S, Wignall FS, Hoffman SL, 1995. Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine. J Infect Dis 171: 1678-1682.
22. Than M, Kyaw MR Soe AY, Gyi KK, Sabai M, Oo M, 1995. Development of resistance to chloroquine by Plasmodium vivax in Myanmar. Trans R Soc Trop Med Hyg 89: 307-308.
23. Areas AE, Corredor A, 1989. Low response of Colombian strains of Plasmodium vivax to classical antimalarial therapy. Trop Med Parasitol 40: 21-23.
24. Hacket LW, 1937. Malaria in Europe. London: Oxford University Press.
25. Shannon JA, 1945-1946. The study of antimalarials and antimalarial activity in the human malarias. The Harvey Lecture Series XLI: 43-49.
26. Shannon JA, Earle DE Jr, Berliner RW, Tarrart JV, 1948. Studies on the chemotherapy of human malaria. I. Methods for the quantitative assay of suppressive antimalarial action in vivax malaria. J Clin Invest 27 part II: 66-74.
27. World Health Organization, 1969. Parasitology of malaria. World Health Organ Tech Rep Ser 433: 28-29.
28. Bruce-Chwatt L, 1964. Changing tides of chemotherapy of malaria. Br Med J i: 581-586.
29. Clyde DF, 1974. Treatment of drug resistant malaria in man. Bull World Health Organ 50: 243-249.
30. Coatney GR, Cooper WC, Young MD, 1950. Studies in human malaria. XXX. A summary of 204 sporozoite-induced infections with the Chesson strain of Plasmodium vivax. J Natl Malaria Soc 9: 381-396.
31. Coatney GR, Cooper WC, Ruhe DS, Young MD, Burgess RW, 1950. Studies in human malaria. XVIII. The life pattern of sporozoite-induced St. Elizabeth strain vivax malaria. Am J Hyg 51: 200-215.
32. Garnham PCC, Bray RS, Bruce-Chwatt LJ, Draper CC, KillickKendrick R, Sergiev PC, Tiburskaja NA, Shute PG, Maryon M, 1975. A strain of Plasmodium vivax characterized by prolonged incubation: morphological and biological characteristics. Bull World Health Organ 52: 21-30.
33. Shute PG, Lupascu Gh, Branzei P, Maryon M, Constantinescu P, Bruce-Chwatt LJ, Draper CC, Killick-Kendrick R, Garnham PCC, 1976. A strain of Plasmodium vivax characterized by prolonged incubation: the effect of numbers of sporozoites on the length of the prepaient period. Trans R Soc Trop Med Hyg 70: 474-481.
34. Nikolaev BP, 1949. Subspecies of the tertian malaria (Plasmodium vivax). Dokl Akad Nauk 67: 201-204.
35. Chiang CP, Yu SY, 1965. A comparison of the morphology between Plasmodium multinucleatum and two other closely related species. Acta Parasitol Sinica 2: 333-340.
36. Jiang CP, Yu SY, Chen JK, 1965. A new subspecies of human malaria, Plasmodium vivax multinucleatum in China. J Chungshan University 1: 131-132.
37. Edgcomb JH, Arnold J, Yount EH, Alving AS, Eichenberger L, Jeffery GM, Eyles DE, Young MD, 1950. Primaquine, SN 13272, a new curative agent in vivax malaria: a preliminary report. J Natl Malaria Soc 9: 285-292.
38. Cooper WC, Myatt AV, Hernandez T, Jeffery GM, Coatney GR, 1953. Studies on human malaria. XXX. Comparison of primaquine, isopentaquine, SN-3883 and pamaquine as curative agents against sporozoite-induced Chesson strain vivax malaria. Am J Trop Med Hyg 2: 949-957.
39. Coatney GR, Getz ME, 1962. Primaquine and quinocide as curative agents against sporozoite-induced Chesson strain vivax malaria. Bull World Health Organ 27: 290-293.
40. Clyde DF, McCarthy VC, 1977. Radical cure of Chesson strain vivax malaria in man. Am J Trop Med Hyg 26: 562-563.
41. Garrison PL, Coker WG, Jastremski B, Coatney GR, Alving AS, Jones R, 1952. Status of primaquine. 2. Cure of Korean vivax malaria with pamaquine and primaquine. JAMA 149: 1562-1563.
42. Alving AS, Hankey DD, Coatney GR, Jones R, Coker WG, Garrison PL, Donovan WN, 1953. Korean vivax malaria. II. Curative treatment with pamaquine and primaquine. Am J Trop Med Hyg 6: 970-976.
43. Coatney GR, Alving AS, Jones R, Hankey DD, Robinson DH, Garrison PL, Coker WG, Donovan WN, DiLorenzo A, Marx RL, Simmons IH, 1953. Korean vivax malaria. V. Cure of the infection by primaquine administered during long-term latency. Am J Trop Med Hyg 6: 985-988.
44. Vivona S, Brewer GJ, Conrad M, Alving AS, 1961. The concurrent weekly administration of chloroquine and primaquine for the prevention of Korean vivax malaria. Bull World Health Organ 25: 267-269.
45. White WC, Cooper WC, Coatney GR, Culwell WB, Lints HA, Young MD, 1948. Studies in human malaria, XXI. The cure of St. Elizabeth strain vivax malaria by pentaquine-quinine, administered during acute attacks or during latency. J Natl Malaria Soc 7: 316-321.
46. Ruhe DS, Cooper WC, Coatney GR, Josephson ES, 1949. Studies in human malaria. XV. The therapeutic action of pamaquine (plasmochin) against St. Elizabeth strain vivax malaria. Am J Hyg 49: 367-373.
47. Fisher GU, Gordon MP, Lobel HO, Runcik K, 1970. Malaria in soldiers returning from Vietnam. Am J Trop Med Hyg 19: 27-39.
48. Tarlov AR, Brewer GJ, Carson PE, Alving AS, 1962. Primaquine sensitivity. Arch Intern Med 109: 209-234.
49. Powell RD, 1966. The chemotherapy of malaria. Clin Pharmacol Ther 7: 48-76.
50. Clyde DF, 1981. Clinical problems associated with the use of primaquine as a tissue schizoncidal and gametocytocidal drug. Bull World Health Organ 59: 391-395.
51. World Health Organization, 1990. Practical chemotherapy of malaria: report of a WHO scientific group. World Health Organ Tech Rep Ser 805: 34-35.
52. Blumel P, Stogmann W, 1983. Manifestation eines glucose-6phosphate dehydrogenase-Mangels durch primaquin bei malariatherapie. Pediatr Padol 18: 313-317.
53. Goldsmid JM, Jupe D, Melrose W, 1984. Primaquine, malaria chemotherapy and G-6-PD deficiency. Med J Aust 141: 310-311.
54. Karwacki JJ, Shanks, Kummalue T, Watanasook C, 1989. Primaquine induced hemolysis in a Thai soldier. Southeast Asian J Trop Med Public Health 20: 555-556.
55. Reeve PA, Toaliu H, Kaneko A, Hall JJ, Ganczakowski M, 1992. Acute intravascular haemolysis in Vanuatu following a single dose of primaquine in individuals with glucose-6-phosphate dehydrogenase deficiency. J Trop Med Hyg 95: 349351.
56. Bouma MJ, Goris M, Aktar T, Khan N, Kita E, 1995. Prevalence and clinical presentation of glucose-6-phosphate dehydrogenase deficiency in Pakistani Pathan and Afghan refugee communities in Pakistan; implications for the use of primaquine in regional malaria control programmes. Trans R Soc Trop Med Hyg 89: 62-64.
57. Cohen RJ, Sachs JR, Wicker DJ, Conrad ME, 1968. Methaemaglobinanemia provoked by malaria chemoprophylaxis in Vietnam. N Eng! J Med 279: 1127-1131.
58. Chan TK, Todd D, Tso SC, 1976. Drug-induced haemolysis in glucose-6-phosphate dehydrogenase deficiency. Br Med J ii: 1227-1229.
59. Pukrittayakamee S, Vanijanonta S, Chantra A, Clemens R, White NJ, 1994. Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria. J Infect Dis 169: 932-935.
60. Thompson PE, 1967. Parasite chemotherapy. Anna Rev Pharmacol 7: 77-100.
61. Arnold J, Alving AS, dayman CB, 1961. Induced primaquine resistance in vivax malaria. Trans R Soc Trop Med Hyg 55: 345-350.
62. Rieckmann KH, Yeo AE, Davis DR, Mutton DC, Wheatley PF, Simpson R, 1993. Recent military experience with malaria chemoprophylaxis. Med J Aust 158: 446-449.
63. Fryauff DJ, Baird JK, Basri H, Sumawinata I, Purnomo, Richie TL, Ohrt CK, Mouzin E, Church CJ, Richards AL, Subianto B, Sandjaja B, Wignall FS, Hoffman SL, 1995. Randomized placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria. Lancet 346: 1190-1193.
64. Jeffery GM, 1956. Relapses with Chesson strain Plasmodium vivax following treatment with chloroquine. Am J Trop Med Hyg 5: 1-13.
65. Young MD, 1959. The effect of small doses of primaquine upon malaria infections. Indian J Malarial 13: 69-74.